indoleamine 2,3-dioxygenase

You have access
Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition
YUMI YOKOTA, HIROAKI NOZAWA, HIROFUMI SONODA, YUICHIRO YOKOYAMA, SHIGENOBU EMOTO, KOJI MURONO, KAZUHITO SASAKI and SOICHIRO ISHIHARA

Anticancer Research August 2024, 44 (8) 3337-3342; DOI: https://doi.org/10.21873/anticanres.17153
You have access
The Impact of Indoleamine 2,3-dioxygenase (IDO) Expression on Stage III Gastric Cancer
MASAAKI NISHI, KOZO YOSHIKAWA, JUN HIGASHIJIMA, TAKUYA TOKUNAGA, HIDEYA KASHIHARA, CHIE TAKASU, DAICHI ISHIKAWA, YUMA WADA and MITSUO SHIMADA

Anticancer Research June 2018, 38 (6) 3387-3392; DOI: https://doi.org/10.21873/anticanres.12605
You have access
Expression of Indoleamine 2,3-Dioxygenase Gene Is a Feature of Poorly Differentiated Non-muscle-invasive Urothelial Cell Bladder Carcinomas
TVRTKO HUDOLIN, CHANTAL MENGUS, JULIE COULOT, ZELJKO KASTELAN, AHMAD EL-SALEH and GIULIO C. SPAGNOLI

Anticancer Research March 2017, 37 (3) 1375-1380;

Main menu